Stoop H - Search Results

1

Patient with two secondary somatic-type malignancies in a late recurrence of a testicular non-seminoma: illustration of potential and flaw of the cancer stem cell therapy concept.

Oosterhuis JW, Peeters SH, Smit VT, Stoop H, Looijenga LH, Elzevier HW, Osanto S. Oosterhuis JW, et al. Among authors: stoop h. Int J Dev Biol. 2013;57(2-4):153-7. doi: 10.1387/ijdb.130141jo. Int J Dev Biol. 2013. PMID: 23784825 Free article.

2

Role of epigenetics in the etiology of germ cell cancer.

Van Der Zwan YG, Stoop H, Rossello F, White SJ, Looijenga LH. Van Der Zwan YG, et al. Among authors: stoop h. Int J Dev Biol. 2013;57(2-4):299-308. doi: 10.1387/ijdb.130017ll. Int J Dev Biol. 2013. PMID: 23784841 Free article. Review.

3

Testicular cancer: biology and biomarkers.

Looijenga LH, Stoop H, Biermann K. Looijenga LH, et al. Among authors: stoop h. Virchows Arch. 2014 Mar;464(3):301-13. doi: 10.1007/s00428-013-1522-1. Epub 2014 Feb 1. Virchows Arch. 2014. PMID: 24487784 Review.

4

Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development.

Dorssers LCJ, Gillis AJM, Stoop H, van Marion R, Nieboer MM, van Riet J, van de Werken HJG, Oosterhuis JW, de Ridder J, Looijenga LHJ. Dorssers LCJ, et al. Among authors: stoop h. Br J Cancer. 2019 Feb;120(4):444-452. doi: 10.1038/s41416-019-0381-1. Epub 2019 Feb 11. Br J Cancer. 2019. PMID: 30739914 Free PMC article.

5

Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance.

Looijenga LH, Gillis AJ, Stoop H, Biermann K, Oosterhuis JW. Looijenga LH, et al. Among authors: stoop h. Int J Androl. 2011 Aug;34(4 Pt 2):e234-51. doi: 10.1111/j.1365-2605.2011.01157.x. Epub 2011 May 12. Int J Androl. 2011. PMID: 21564133 Review.

6

VASA is a specific marker for both normal and malignant human germ cells.

Zeeman AM, Stoop H, Boter M, Gillis AJ, Castrillon DH, Oosterhuis JW, Looijenga LH. Zeeman AM, et al. Among authors: stoop h. Lab Invest. 2002 Feb;82(2):159-66. doi: 10.1038/labinvest.3780408. Lab Invest. 2002. PMID: 11850529 Free article.

7

Molecular determinants of treatment response in human germ cell tumors.

Mayer F, Stoop H, Scheffer GL, Scheper R, Oosterhuis JW, Looijenga LH, Bokemeyer C. Mayer F, et al. Among authors: stoop h. Clin Cancer Res. 2003 Feb;9(2):767-73. Clin Cancer Res. 2003. PMID: 12576448

8

POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.

Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G, Oosterhuis JW. Looijenga LH, et al. Among authors: stoop h. Cancer Res. 2003 May 1;63(9):2244-50. Cancer Res. 2003. PMID: 12727846

9

Aneuploidy of human testicular germ cell tumors is associated with amplification of centrosomes.

Mayer F, Stoop H, Sen S, Bokemeyer C, Oosterhuis JW, Looijenga LH. Mayer F, et al. Among authors: stoop h. Oncogene. 2003 Jun 19;22(25):3859-66. doi: 10.1038/sj.onc.1206469. Oncogene. 2003. PMID: 12813459

10

12p-amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH.

Zafarana G, Grygalewicz B, Gillis AJ, Vissers LE, van de Vliet W, van Gurp RJ, Stoop H, Debiec-Rychter M, Oosterhuis JW, van Kessel AG, Schoenmakers EF, Looijenga LH, Veltman JA. Zafarana G, et al. Among authors: stoop h. Oncogene. 2003 Oct 23;22(48):7695-701. doi: 10.1038/sj.onc.1207011. Oncogene. 2003. PMID: 14576833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page